These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24020956)

  • 1. Prevention of migraine.
    Tepper D
    Headache; 2013 Sep; 53(8):1397-8. PubMed ID: 24020956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention for Pediatric and Adolescent Migraine.
    Hickman C; Lewis KS; Little R; Rastogi RG; Yonker M
    Headache; 2015; 55(10):1371-81. PubMed ID: 26442833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological prevention of migraine.
    Fenstermacher N; Levin M; Ward T
    BMJ; 2011 Feb; 342():d583. PubMed ID: 21335409
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacologic Prevention of Migraine: A Narrative Review of the State of the Art in 2018.
    Loder E; Rizzoli P
    Headache; 2018 Nov; 58 Suppl 3():218-229. PubMed ID: 30137671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foods and supplements in the management of migraine headaches.
    Sun-Edelstein C; Mauskop A
    Clin J Pain; 2009 Jun; 25(5):446-52. PubMed ID: 19454881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting migraine responsiveness to botulinum toxin type A injections.
    Kim CC; Bogart MM; Wee SA; Burstein R; Arndt KA; Dover JS
    Arch Dermatol; 2010 Feb; 146(2):159-63. PubMed ID: 20157026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug treatment of migraine: Part II. Preventive therapy.
    Noble SL; Moore KL
    Am Fam Physician; 1997 Dec; 56(9):2279-86. PubMed ID: 9402813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Narrative Review of Evidence-Based Preventive Options for Chronic Migraine.
    Starling AJ; Vargas BB
    Curr Pain Headache Rep; 2015 Oct; 19(10):49. PubMed ID: 26286071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis of migraine headache.
    Pringsheim T; Davenport WJ; Becker WJ
    CMAJ; 2010 Apr; 182(7):E269-76. PubMed ID: 20159899
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment guidelines for preventive treatment of migraine].
    Treatment Guideline Subcommittee of the Taiwan Headache Society
    Acta Neurol Taiwan; 2008 Jun; 17(2):132-48. PubMed ID: 18686655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive migraine treatment.
    Silberstein SD
    Neurol Clin; 2009 May; 27(2):429-43. PubMed ID: 19289224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and preventive treatment of migraine.
    Rizzoli PB
    Continuum (Minneap Minn); 2012 Aug; 18(4):764-82. PubMed ID: 22868540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duloxetine prophylaxis for episodic migraine in persons without depression: a prospective study.
    Young WB; Bradley KC; Anjum MW; Gebeline-Myers C
    Headache; 2013 Oct; 53(9):1430-7. PubMed ID: 24032526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which therapy for which patient?
    Pierangeli G; Cevoli S; Sancisi E; Grimaldi D; Zanigni S; Montagna P; Cortelli P
    Neurol Sci; 2006 May; 27 Suppl 2():S153-8. PubMed ID: 16688621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological prevention of migraine.
    Rapoport AM
    Clin Neurosci; 1998; 5(1):55-9. PubMed ID: 9523060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Migraine preventive therapy: current and emerging treatment options.
    Rapoport AM; Bigal ME
    Neurol Sci; 2005 May; 26 Suppl 2():s111-20. PubMed ID: 15926007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive treatment of migraine.
    Silberstein SD
    Rev Neurol Dis; 2005; 2(4):167-75. PubMed ID: 16622394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients' preference for migraine preventive therapy.
    Peres MF; Silberstein S; Moreira F; Corchs F; Vieira DS; Abraham N; Gebeline-Myers C
    Headache; 2007 Apr; 47(4):540-5. PubMed ID: 17445103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antidepressants in migraine prophylaxis].
    Nagata E
    Brain Nerve; 2009 Oct; 61(10):1131-4. PubMed ID: 19882939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future trends in drugs for migraine prophylaxis.
    Barbanti P; Aurilia C; Egeo G; Fofi L
    Neurol Sci; 2012 May; 33 Suppl 1():S137-40. PubMed ID: 22644189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.